DCTH (Delcath Systems) EPS (Basic): $0.02 (TTM As of Mar. 2026)

What is Delcath Systems EPS (Basic)?

Delcath Systems DCTH -0.41% 70 EPS (Basic) is $0.02 as of Mar. 2026. GuruFocus rates DCTH with a GF Score™ of 70/100 and a GF Value™ of $36.69 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Delcath Systems's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $-0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02.

Delcath Systems's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01.

Delcath Systems's EPS without NRI for the three months ended in Mar. 2026 was $-0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Delcath Systems's highest 3-Year average EPS without NRI Growth Rate was 96.30% per year. The lowest was 30.80% per year. And the median was 83.70% per year.

Delcath Systems (NAS:DCTH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Delcath Systems EPS (Basic) Related Terms

Delcath Systems EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Delcath Systems's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delcath Systems EPS (Basic) Chart

Delcath Systems Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

-3.59

-4.12

-2.94

-0.93

0.08

Delcath Systems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															0.03	0.08	0.02	-0.05	-0.03

70GF Score

Delcath Systems Inc DCTH

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Delcath Systems EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Delcath Systems's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2.7	-	0)	/	35.821
	=	0.08

Delcath Systems's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.07	-	0)	/	36.021
	=	-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $0.02 mean?

Delcath Systems (DCTH) has a EPS (Basic) of $0.02 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Delcath Systems and its competitors.

Is Delcath Systems' EPS (Basic) too high?

Delcath Systems' current EPS (Basic) is $0.02. Overall, Delcath Systems has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Delcath Systems' EPS (Basic) compare to OFIX and VMD?

Delcath Systems' EPS (Basic) of $0.02 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Delcath Systems and its competitors. Delcath Systems's current EPS (Basic) is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Delcath Systems stock overvalued right now?

Based on GuruFocus' analysis, Delcath Systems (DCTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $36.69, compared to a current price of $12.23 — trading 66.7% below its estimated fair value. The current EPS (Basic) is $0.02. Delcath Systems' overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Delcath Systems (DCTH), the current EPS (Basic) is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Delcath Systems (DCTH) Overvalued in 2026?

Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued. The current stock price of $12.23 is trading 66.7% below its estimated GF Value™ of $36.69. GuruFocus considers Delcath Systems to be Significantly Undervalued.

Key valuation signals for DCTH:

EPS (Basic): $0.02
GF Value™: $36.69 vs. price of $12.23 (66.7% below fair value)
GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the DCTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Delcath Systems Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OFIX VMD CLPT SENS CV MASS VREX ELMD SI KIDS ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges DV3R:Germany

Address 566 Queensbury Avenue, Queensbury, NY, USA, 12804

Website https://www.delcath.com

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

70GF Score

Get the complete analysis for DCTH

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.23

Price

$36.69

GF Value

View DCTH Analysis

See EPS (Basic) data for all stocks →